insights from industryBernd GleixnerDivision President AutomationBruker Biopsin News Medical speaks to Bernd Gleixner, Division President Automation at Bruker Biospin, about the future of lab ...
Autonomy, by contrast, is about decision‑making and adaptation. The leap from automation to autonomy is not just more actuators; it is a system that can perceive its environment, reason about options, ...
Lilly and NVIDIA launch AI co-innovation lab to tackle drug discovery challenges.NVIDIA collaborates with Thermo Fisher to build ...
Nvidia expands BioNeMo for AI drug discovery with new models, tools, and lab partnerships to automate experiments and speed ...
At the J.P. Morgan Healthcare Conference, Nvidia announced major AI partnerships with Lilly and Thermo Fisher Scientific to ...
South San Francisco is poised to become an even hotter address for biotech and chip companies. Nvidia and Eli Lilly said Monday they are teaming up on a co-innovation artificial intelligence lab in ...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with NVIDIA to power AI-based solutions and laboratory automation at scale. The ...
Milton Yu, PhD, is the head of automation and analytics strategy at Benchling. Prior to Benchling, he was principal product manager at AWS and a director of GTM at Microsoft. Milton received his cell ...
Expanded our physical footprint to 20 major cities and integrated 50%+ new experiences. TORONTO, ON AND NEW YORK, NY / ...
Across all included studies, AI-based diagnostic systems demonstrated high overall accuracy. When measured against expert ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results